Awardee OrganizationUNIVERSITY OF TEXAS SAN ANTONIO
Description
Abstract Text
The U.S. needs a strong, diverse workforce of PhD-level scientists and engineers to meet emerging healthcare
challenges. The long-term goal of the renewed UTSA ESTEEMED Program is to cultivate an exceptional cohort
of lower division Biomedical Engineering (BME) and Chemical Engineering (CME) undergraduates (UGs), who
are underrepresented (UR) racially, economically, or through disability. Trainees will bring diverse viewpoints
and approaches to address these healthcare challenges. ESTEEMED trainees will develop strong academic and
research foundations, as well as the drive and vision to complete doctoral training programs and launch into
impactful biomedical research careers. UTSA is an excellent training ground for these future scientists, with a
large UR student population, excellent academic programs, and laboratories that perform high quality biomedical
research and embrace UG researchers. The first ESTEEMED program laid strong foundations for success. Now
the program will be refined to serve students with a bioengineering focus. The proposed ESTEEMED program
requests 13 training positions in its first year and 12 thereafter to support first- and second- year students. We
hypothesize that we will build strong foundations for our trainees and start their trajectory to a doctorate, through
accomplishment of the following Specific Aims: #1 support academic achievement with science refreshers,
tutoring, and mentoring; #2 support growth as a scientist and science communicator; #3 instruct trainees about
diverse doctoral-level career options; and #4 promote leadership development and address known barriers to
UG and Ph.D. degree attainment in UR populations. The activities designed to achieve these Aims will
commence in a pre-Freshman Bridge Program, extend throughout all semesters of the freshman and sophomore
years, and include part-time research through the academic years and two full-time intramural and extramural
summer research programs. Eighteen diverse UTSA research mentors (8 Hispanic and 6 women) with active
biomedical-focused research programs have been recruited because of their strong passion for mentoring UGs.
UTSA was awarded a new MARC Honors Research Training Program in 2022 that will provide upper division
training. The success of ESTEEMED will be measured quantitively by the following outcomes: 95% of trainees
will complete their degree, 75% will progress to MARC and 75% of MARC matriculants will pursue a PhD, 90%
trainees will keep a GPA>3.4, all sophomore trainees will present at several local and one national conference,
and 30% will gain authorship by graduation. Qualitatively, success will be reflected by reported increases in
confidence and integration into science culture. Program success will provide evidence for inclusion of additional
freshman interventions on campus. ESTEEMED will be run by a leadership team that has an established record
of success in UG research training programs. UTSA’s administration has committed substantial financial and
operational support for ESTEEMED.
Public Health Relevance Statement
Increasing the number of researchers from scientifically-underrepresented groups will promote biomedical
advancement in the United States. The proposed ESTEEMED Research Program will identify high-achieving
underrepresented freshmen and support them as they develop as biomedical scientists. The students will
engage in meaningful year-round biomedical research projects; receive mentoring, academic assistance, and
personal and professional development trainings; and develop the credentials needed to enter UTSA’s MARC
Honors Research Training Program as juniors, and later complete biomedical doctoral degrees and attain
leadership positions in the scientific community.
NIH Spending Category
No NIH Spending Category available.
Project Terms
Academic achievementAcademic supportAchievementAddressAdmission activityAuthorshipAwardBachelor's DegreeBasic ScienceBiomedical EngineeringBiomedical ResearchCCL7 geneCareer ChoiceCensusesChemical EngineeringClassificationCommunicationCommunitiesComputersCredentialingDegree CompletionDevelopmentDevelopment PlansDisabled PersonsDiverse WorkforceDoctor of PhilosophyDoctor's DegreeEducationEducational CurriculumEducational workshopEngineeringEthnic OriginExtramural ActivitiesFacultyFoundationsFundingFutureGoalsGrowthHealthcareHispanicHispanic PopulationsHispanic-serving InstitutionIndividualInterventionLaboratoriesLaboratory ResearchLeadershipLettersLibrariesMeasurableMeasuresMedical Device DesignsMentorsMinorityMinority ParticipationMonitorNational Institute of Biomedical Imaging and BioengineeringOralOutcomePaperPopulationPopulation HeterogeneityPositioning AttributePublicationsPublished CommentPublishingRaceReportingResearchResearch ActivityResearch PersonnelResearch Project GrantsResearch SupportResearch TrainingRoleRunningScienceScientistSelf EfficacyStudentsStudy SkillsTalentsTechnologyTexasTimeTrainingTraining ProgramsUnderrepresented MinorityUnderrepresented PopulationsUnderrepresented StudentsUnited StatesUnited States National Academy of SciencesUniversitiesUpdateVisionWashingtonWomanWritingacademic programbiomedical imagingbiomedical scientistbridge programcareercohortcollegedesigndisabilityeducation researchevidence baseexperiencefield tripinsightinterestleadership developmentlecturesmatriculationnext generationoutreachpeer coachingprogramsrecruitrole modelskillssuccesssummer programsummer researchsymposiumtutoringundergraduate researchundergraduate student
National Institute of Biomedical Imaging and Bioengineering
CFDA Code
286
DUNS Number
800189185
UEI
U44ZMVYU52U6
Project Start Date
23-July-2019
Project End Date
31-March-2028
Budget Start Date
05-April-2024
Budget End Date
31-March-2025
Project Funding Information for 2024
Total Funding
$320,568
Direct Costs
$296,822
Indirect Costs
$23,746
Year
Funding IC
FY Total Cost by IC
2024
National Institute of Biomedical Imaging and Bioengineering
$320,568
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R25EB027605-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R25EB027605-06
Patents
No Patents information available for 2R25EB027605-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R25EB027605-06
Clinical Studies
No Clinical Studies information available for 2R25EB027605-06
News and More
Related News Releases
No news release information available for 2R25EB027605-06
History
No Historical information available for 2R25EB027605-06
Similar Projects
No Similar Projects information available for 2R25EB027605-06